Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Additional investment builds on EF’s existing commitment and will go towards building Tour de France Femmes winning squad and long-term talent development on men’s and
CGTN published an article on UK Prime Minister Keir Starmer’s visit to China, highlighting that amid rising global uncertainty, Beijing and London are placing greater
JINAN, China, Jan. 29, 2026 (GLOBE NEWSWIRE) — Bodor Laser, a global manufacturer of laser cutting solutions, has announced the launch of its SK Series
SAN JOSE, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the fourth
MIKOŁÓW, Poland, Jan. 29, 2026 (GLOBE NEWSWIRE) — Dictador, Colombia’s iconic luxury rum house, announces the appointment of Will Smith as Global Artistic Director, signaling
